The use of novel oral anticoagulants: the debate continues!
- PMID: 25845033
- PMCID: PMC4385060
- DOI: 10.2450/2015.0059-15
The use of novel oral anticoagulants: the debate continues!
Comment on
-
The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations.Blood Transfus. 2015 Apr;13(2):178-80. doi: 10.2450/2015.0002-15. Blood Transfus. 2015. PMID: 25845034 Free PMC article. Review. No abstract available.
-
Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority.Blood Transfus. 2015 Apr;13(2):181-3. doi: 10.2450/2015.0057-15. Blood Transfus. 2015. PMID: 25845035 Free PMC article. Review. No abstract available.
References
-
- Franchini M, Mengoli C, Cruciani M, et al. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. J Thromb Haemost. 2014;12:1480–7. - PubMed
-
- Franchini M, Mannucci PM. A new era for anticoagulants. Eur J Intern Med. 2009;20:562. - PubMed
-
- Prandoni P. Venous thromboembolism in 2013: the advent of the novel oral anticoagulants. Nat Rev Cardiol. 2014;11:70–2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical